A detailed history of Exchange Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exchange Bank holds 29,845 shares of BMY stock, worth $1.76 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
29,845
Previous 29,845 -0.0%
Holding current value
$1.76 Million
Previous $1.24 Billion 24.58%
% of portfolio
1.26%
Previous 1.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$40.25 - $52.99 $39,123 - $51,506
-972 Reduced 3.15%
29,845 $1.24 Billion
Q1 2024

Apr 12, 2024

SELL
$47.98 - $54.4 $14,202 - $16,102
-296 Reduced 0.95%
30,817 $1.67 Billion
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $24,627 - $29,387
-508 Reduced 1.61%
31,113 $1.6 Billion
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $23,156 - $25,892
-400 Reduced 1.25%
31,621 $1.84 Billion
Q2 2023

Nov 15, 2023

BUY
$63.71 - $70.74 $2.04 Million - $2.27 Million
32,021 New
32,021 $2.05 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Exchange Bank Portfolio

Follow Exchange Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Bank, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Bank with notifications on news.